IP Library Granted Patent US 11,952,614
Granted Patent B2
US 11,952,614 · App. 17/147,826 · Granted Apr 9, 2024

Bead beating tube and method for extracting deoxyribonucleic acid and/or ribonucleic acid from microorganisms

Inventors: Holger Klapproth (Freiburg, DE); Nicolaas Smit (Welland, CA)
Assignee: Safeguard Biosystems Holdings Ltd.
C12Q1/6806B01L3/5082C12M47/06C12Q1/6874B01L2300/16G01N2035/00524
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,952,614
App. No.
17/147,826
Granted
Apr 9, 2024
Kind
B2
Abstract

The present disclosure provides improved methods for bead beating and a bead beating system useful therefor. The bead beating system comprises a sample tube, beads, and a dry blocking agent, and methods for using the bead beating system to extract nucleic acids from cells containing the nucleic acids.

Claims (34)

1. A method for producing a lysate from cells contained in a blood sample, comprising agitating the blood sample within a bead beating system in the absence of a buffer, in the absence of a detergent, and in the presence of one or more endogenous blocking agents comprising urea under conditions sufficient to (i) lyse both a fungal pathogen and a bacterial pathogen and (ii) provide a lysate suitable for PCR amplification of DNA from the fungal pathogen, when present, and the bacterial pathogen, when present, said bead beating system comprising a bead beating tube and beads.

2. The method of claim 1 , wherein the agitating is carried out in the absence of any additives.

3. The method of claim 1 , wherein the beads:

a) are adapted to lyse yeast or filamentous fungi;

b) comprise:

i. mineral beads, ceramic beads, glass beads, metal beads, or a combination thereof;

ii. zirconium beads, zircon beads, zirconia beads, quartz beads, aluminum oxide beads, silicon carbide beads, ceramic beads, silicon dioxide glass beads, stainless steel beads, chrome steel beads, or a combination thereof;

c) have a diameter ranging from 50 μm to 3 mm; or

d) any combination of a)-c).

4. The method of claim 1 , further comprising a step of placing the blood within the bead beating tube prior to agitating the blood.

5. The method of claim 1 , which comprises agitating the blood under conditions sufficient to (i) lyse Candida albicans and (ii) provide a lysate suitable for PCR amplification of DNA from Candida albicans , when the Candida albicans is present.

6. The method of claim 1 , which comprises agitating the blood under conditions sufficient to (i) lyse Staphylococcus aureus and (ii) provide a lysate suitable for PCR amplification of DNA from Staphylococcus aureus , when the Staphylococcus aureus is present.

7. The method of claim 5 , which comprises agitating the blood under conditions sufficient to (i) lyse Staphylococcus aureus and (ii) provide a lysate suitable for PCR amplification of DNA from Staphylococcus aureus , when the Staphylococcus aureus is present.

8. The method of claim 1 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.

9. The method of claim 5 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.

10. The method of claim 6 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.

11. The method of claim 7 , which comprises agitating the blood under conditions sufficient to (i) lyse Escherichia coli and (ii) provide a lysate suitable for PCR amplification of DNA from Escherichia coli , when the Escherichia coli is present.

12. The method of claim 1 , wherein the agitating comprises subjecting the bead beating system to an oscillating motion.

13. The method of claim 12 , wherein the agitating comprises subjecting the bead beating system to 2000 or more oscillations per minute.

14. The method of claim 1 , wherein the agitating is performed with a vortexer or a homogenizer.

15. The method of claim 14 , wherein the agitating is performed with a homogenizer.

16. The method of claim 15 , wherein the agitating is performed for 25-60 seconds.

17. The method of claim 15 , wherein the agitating is performed for 1-2 minutes.

18. The method of claim 1 , wherein the blood comprises one or more pathogens.

19. The method of claim 18 , wherein the one or more pathogens comprise one or more bacterial pathogens, viral pathogens, fungal pathogens, or a combination thereof.

20. The method of claim 19 , wherein the one or more pathogens comprise Candida albicans.

21. The method of claim 19 , wherein the one or more pathogens comprise Staphylococcus aureus.

22. The method of claim 19 , wherein the one or more pathogens comprise Escherichia coli.

23. The method of claim 1 , wherein the blood comprises cells from multiple species.

24. The method of claim 1 , further comprising recovering the lysate from the bead beating tube following cell lysis.

25. The method of claim 24 , further comprising purifying nucleic acids from the lysate.

26. The method of claim 1 , further comprising analyzing one or more nucleic acids from the lysate.

27. The method of claim 26 , wherein the analyzing comprises PCR to amplify DNA from the fungal pathogen, when present, and DNA from the bacterial pathogen, when present.

28. The method of claim 27 , further comprising using a microarray to analyze the one or more nucleic acids or sequencing the one or more nucleic acids following PCR.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2024
From: IP SUCCESSOR FUND 21 L.P.
To: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
Reel/Frame 069084/0644 →
RELEASE OF SECURITY INTEREST Recorded Oct 31, 2024
From: MLC50 LP INC.
To: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
Reel/Frame 069084/0649 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2024
From: SAFEGUARD BIOSYSTEMS HOLDING LIMITED
To: SAFEGUARD DX LIMITED
Reel/Frame 069088/0245 →
SECURITY INTEREST Recorded Aug 16, 2024
From: SAFEGUARD BIOSYSTEMS HOLDINGS LIMITED
To: MLC50 LP INC.
Reel/Frame 068317/0453 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2024
From: SAFEGUARD BIOSYSTEMS HOLDINGS LTD.
To: IP SUCCESSOR FUND 21 L.P.
Reel/Frame 066668/0727 →
Priority Claims (1)
EP 16153540 · Jan 30, 2016 · regional
Continuity (4)
Division 16023492 · Jun 29, 2018
Division 15432157 · Feb 14, 2017
Continuation PCTEP2017051902 · Jan 30, 2017
Related Publication 20210139952A1 · May 13, 2021